US · Healthcare

EXACT Sciences Corporation (EXAS)

Diagnostics & Research

EXACT Sciences Corporation (EXAS) is listed on US in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for EXAS

P/E ratio

18.00

EXACT Sciences Corporation (EXAS) — FAQ

What is EXAS's P/E ratio?

The price-to-earnings (P/E) ratio for EXACT Sciences Corporation (EXAS) is 18.00 (data as of 2026-03-23).

Does EXACT Sciences Corporation pay a dividend?

Dividend yield is not available in the current snapshot for EXACT Sciences Corporation (EXAS). Check the MyAverix Finance app for the latest dividend data.

What sector is EXACT Sciences Corporation in?

EXACT Sciences Corporation (EXAS) is classified in the Healthcare sector (Diagnostics & Research industry).

What exchange is EXAS listed on?

EXAS is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)